|
Volumn 33, Issue 7-8, 2001, Pages 3215-3220
|
The role of Certican (Everolimus, Rad) in the many pathways of chronic rejection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CALCINEURIN INHIBITOR;
CORTICOSTEROID;
CYCLOSPORIN A;
EVEROLIMUS;
INTERLEUKIN 15;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PLACEBO;
S6 KINASE;
TACROLIMUS;
CELL CYCLE;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
DRUG MECHANISM;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
LYMPHOCYTE PROLIFERATION;
NEPHROTOXICITY;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SIGNAL TRANSDUCTION;
|
EID: 0035671844
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02369-7 Document Type: Article |
Times cited : (37)
|
References (48)
|